HPV serostatus pre- and post-vaccination in a randomized phase II preparedness trial among young Western Cape, South African women: The evri trial

HPV serostatus pre- and post-vaccination in a randomized phase II preparedness trial among young Western Cape, South African women: The evri trial

Background: HPV antibodies are a marker of past exposure to the virus. Our objective was to assess HPV serostatus pre- and post-vaccination among HIV-negative women. Methods: Women aged 16â24 years old were randomized in a placebo controlled trial utilizing the 4-valent HPV (4vHPV) vaccine (NCT01489...

Full description

Bibliographic Details
Main Authors: Staci L. Sudenga, B. Nelson Torres, Matthys H. Botha, Michele Zeier, Martha E. Abrahamsen, Richard H. Glashoff, Susan Engelbrecht, Maarten F. Schim Van der Loeff, Louvina E. Van der Laan, Siegfried Kipping, Douglas Taylor, Anna R. Giuliano
Format: Article
Language:English
Published: Elsevier 2017-06-01
Series:Papillomavirus Research
Online Access:http://www.sciencedirect.com/science/article/pii/S240585211630060X

Internet

http://www.sciencedirect.com/science/article/pii/S240585211630060X

Similar Items